| 摘要 |
PROBLEM TO BE SOLVED: To provide an antitumor agent having ERas gene expression-inhibiting activities. SOLUTION: The antitumor agent contains a tetrahydroisoquinoline derivative [e.g. 2-(4-acetyl-phenylazo)-2-(3,3-dimethyl-3,4-dihydro-2H-isoquinolin-1-ylidene)-acetamide] having the expression-inhibiting activities of the ERas gene, or a pharmacologically acceptable salt thereof as an active ingredient. COPYRIGHT: (C)2006,JPO&NCIPI
|
